Friday, 23rd March 2018
Head and Neck Optical Diagnostics and Intervention Society

The International Society of Minimally Invasive Diagnostics and Therapy

Charles William Spangler

Chief Science Officer

SensoPath Technologies, Inc



Research interests

- Two-photon PDT of recurring refractory H&N tumors

- Targeted PDT for cancer treatment

- Image-guided PDT

- treatment of tumors harboring Kras and/or TP53 mutations